At STADA we take pride in our heritage. For more than 120 years, patients and physicians have trusted us to deliver pharmaceutical products that meet the highest standards in quality and safety.
Company of the Year EMEA Award
In 2018 STADA won the Global Generics & Biosimilars Award in the category "Company of the Year, EMEA". Most importantly, we were recognized for implementing strategic acquisitions and cooperations regarding our branded products and biosimilars in less than one year, which has contributed to the expansion and internationalization of our product portfolio.
Growing competence and expertise
We launched our first biosimilar more than ten years ago and have gained experience in the biological treatment field of nephrology and oncology. Moreover, we have multiple medicines in our pipeline, used in other therapeutical areas like ophthalmology and osteoporosis.
STADA makes biologics available to more
STADA is an active member of Medicines for Europe, the European association for generics, biosimilars and value added medicines. Medicines for Europe member companies provide high-quality, cost-competitive medicines to millions of patients in Europe and around the world.